Skip to main content

Elon Musk's Twitter deposition rescheduled for October 6-7

Elon Musk's Twitter deposition rescheduled for October 6-7

 Tesla CEO, Elon Musk, is scheduled to be questioned under oath by Twitter Inc lawyers on October 6-7, according to a Tuesday court filing.

The company prepares for a trial next month over Musk’s bid to walk away from a $44 billion takeover deal. Elon Musk and the social media giant are conducting dozens of depositions and reviewing thousands of documents for the five-day trial starting October 17 in Wilmington, Delaware.

Musk's deposition was originally scheduled for this week. However, the sources close to the litigation said that the timing of the interview was always subject to change because of the fast-tracked nature of the litigation. Reportedly, Musk's deposition is expected to be a key part of the litigation. Twitter's legal team is expected to show that Musk abandoned the deal due to falling financial markets.

In the Elon Musk vs Twitter buyout battle, Twitter wants McCormick to order Musk to close the deal at the agreed price of $54.20 per share. The Tesla owner and billionaire made a hostile bid to take over Twitter at $54.20 per share. However, he backed away from the deal and blamed Twitter for breaching the agreement by misrepresenting the number of fake accounts on the micro-blogging site. However, Twitter said that Musk’s skepticism over spam accounts tally was a distraction to walk away from the deal due to falling financial markets. Twitter also argued that delay can damage its business. According to Twitter, Musk reportedly backed away from the deal because the stocks of Twitter tumbled, and the value had fallen below the $54.20 per share that Musk offered. 

Musk’s legal team has repeatedly told the Delaware Chancery Court that Musk wanted correct details about spam accounts on Twitter. On the other hand, Twitter wanted a commitment from Musk to complete the trial in five days.


Comments

Popular posts from this blog

Netanyahu’s Shocking Gaza Plan: ‘We Will Take Control of ALL of Gaza’ — But At What Cost?

  As Israeli forces intensify their offensive, Netanyahu vows total control of Gaza — but the humanitarian crisis is reaching a breaking point. Will the world stand by and watch? Israeli Prime Minister Benjamin Netanyahu has declared that Israel will “take control of all” of the Gaza Strip, signaling an unprecedented escalation in the ongoing conflict. In a video posted to Telegram, Netanyahu emphasized that military operations are advancing rapidly, with no intention of backing down. “The fighting is intense, and we are making progress,” he said, framing the offensive as necessary for Israel’s long-term security. But as international pressure mounts, his government is walking a tightrope between military dominance and global condemnation. The Israeli military has ordered mass evacuations in southern Gaza, warning residents of Khan Yunis and surrounding areas to flee immediately ahead of a devastating assault. Arabic-language spokesman Avichay Adraee described the coming attack as ...

Israel issues latest forced evacuation order in areas in Khan Younis

  The Israeli army’s Arabic-language spokesperson, Avichay Adraee, has issued the latest forced evacuation order for civilians living in nine areas in Khan Younis, southern Gaza. Adraee said that the army was expanding its operation and “intensifying sudden and concentrated firepower”. The spokesperson called on residents to evacuate westward. So-called Israeli safe zones, including Al-Mawasi in Khan Younis, are routinely attacked despite the army forcing Palestinians to move to those areas.

UAE initiates extensive CAR T-cell treatment in the region

The United Arab Emirates has transformed the medical structure of the region as it slowly moves towards attaining leadership in medical treatments and complex procedures. It has stepped up on the list with a pioneering treatment led by Abu Dhabi. The capital has witnessed a revolutionary process that focuses on the safety and efficacy of using the CAR T-Cell treatment module especially for hematologic or blood cancers such as lymphoma, myeloma, and certain types of leukemia. This is an exemplary step in the context of the region as it is the first of its kind treatment here.  On Saturday, the Emirati nation began its experiment to locally manufacture CAR T-Cell treatment at Abu Dhabi Stem Cells Center. The T-Cells will be locally reprogrammed and tested for their effectiveness so that they get better results when it comes to treating cancer.   The unit for the stem cell treatment ADSCC was founded in 2019 and since then it has grown threefold when it comes to experimenting wit...